Holen Sie sich die Stockscreener-App
2.47
1.59%
-0.04
Schlusskurs vom Vortag:
$2.51
Offen:
$2.56
24-Stunden-Volumen:
586.32K
Relative Volume:
0.68
Marktkapitalisierung:
$204.64M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-2.2252
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
+0.41%
1M Leistung:
+16.51%
6M Leistung:
-36.34%
1J Leistung:
-34.48%
1-Tages-Spanne:
$2.378
$2.575
1-Wochen-Bereich:
$1.95
$2.70
52-Wochen-Spanne:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Vergleichen Sie CDXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.47 | 203.80M | 70.14M | -76.24M | -57.06M | -1.11 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Q1 2025 Earnings Call Transcript - Insider Monkey
Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Stifel Financial Corp - Defense World
Codexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOs - MSN
Stifel maintains Buy rating on Codexis stock with $5 target By Investing.com - Investing.com India
Stifel maintains Buy rating on Codexis stock with $5 target - Investing.com Australia
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with Strategic Growth Initiatives - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings: EPS at -$0.23 and Revenue H - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with ... - Yahoo Finance
Codexis Reports Q1 2025 Financial Results and Strategic Progress - TipRanks
Codexis: Q1 Earnings Snapshot - MySA
Earnings call transcript: Codexis Q1 2025 results miss forecasts, stock declines - Investing.com Nigeria
Codexis (CDXS) Navigates Q1 Revenue Challenges, Confirms 2025 Ou - GuruFocus
Codexis, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:CDXS) - Seeking Alpha
Codexis (CDXS) Projects Financial Stability Until 2026 | CDXS St - GuruFocus
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Codexis (CDXS) Reports Lower Than Expected Q1 Revenue, Affirms 2 - GuruFocus
Codexis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Codexis May 2025 presentation slides: RNA manufacturing pivot targets path to profitability - Investing.com Australia
CODEXIS Earnings Results: $CDXS Reports Quarterly Earnings - Nasdaq
Codexis (CDXS) Reports Lower Than Expected Q1 Revenue, Affirms 2025 Outlook | CDXS Stock News - GuruFocus
Codexis Reports First Quarter 2025 Financial Results - TradingView
Codexis Secures Landmark ECO Synthesis Deal as Q1 Earnings Show Strategic Pivot to RNA Manufacturing - Stock Titan
Thinking Of Selling Codexis Inc (NASDAQ: CDXS) Stock? Check This Out First - Stocksregister
MetLife Investment Management LLC Increases Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis, Inc. (NASDAQ:CDXS) Shares Bought by Wells Fargo & Company MN - Defense World
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Codexis, Inc. (NASDAQ: CDXS) and Encourages CDXS Shareholders to Contact the Firm - ACCESS Newswire
Financial Metrics Exploration: Understanding Codexis Inc (CDXS) Through Ratios - DWinneX
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting - GlobeNewswire
Codexis, Inc. (NASDAQ:CDXS) Stake Increased by Barclays PLC - Defense World
Recent uptick might appease Codexis, Inc. (NASDAQ:CDXS) institutional owners after losing 36% over the past year - simplywall.st
Top 5 Synthetic Biology Public Companies (May 2025) - Securities.io
BlackRock, Inc. Reduces Stake in Codexis Inc. - GuruFocus
Codexis to Report First Quarter 2025 Financial Results on May 14 - The Manila Times
Codexis, Inc. to Release First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq
Codexis Q1 2025 Earnings Call: Key Details for Investors RevealedMark Your Calendar - Stock Titan
Opaleye Management Makes Strategic Move with Codexis Stock Purchase - TipRanks
Codexis, Inc. (NASDAQ:CDXS) Shares Bought by JPMorgan Chase & Co. - Defense World
Envestnet Asset Management Inc. Purchases 110,541 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Codexis Inc (CDXS) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocksregister
Codexis, Inc. (NASDAQ:CDXS) Holdings Decreased by Russell Investments Group Ltd. - Defense World
Codexis Inc [CDXS] Shares Rise 2.24 % on Wednesday - knoxdaily.com
Codexis Inc (CDXS) stock analysis: A comprehensive overview - uspostnews.com
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Geode Capital Management LLC Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis (CDXS) Projected to Post Earnings on Thursday - Defense World
Quarterly Snapshot: Quick and Current Ratios for Codexis Inc (CDXS) - DWinneX
Global Biocatalysis Market Growth Trends & Insights2024-2031 - openPR.com
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
7.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):